Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Eksterne analyser

Nolato: Resilient Medical exposure in a chaotic market - ABG

Nolato

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier.

Download analyse (PDF)
Q1e: a solid quarter with EBITA up 11% y-o-y
Higher estimates following ambitious new targets
Medical (~60% of EBITA) should be resilient in a downturn


Q1e: a solid quarter with EBITA up 11% y-o-y

We expect Nolato to report Q1 net sales of SEK 2,527m, up 3% y-o-y (+3% organic), and EBITA of SEK 264m, for a margin of 10.4% (9.7%); we are roughly in line with FactSet consensus. The cyclical fears driven by tariffs started in April and should not impact the Q1 numbers. As such, we expect a solid quarter in both segments, but we see some increased risk in Engineered in subsequent quarters in case of a general slowdown in economic activity. Medical, however, should be more resilient.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.